Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Alico
ALCO
$283M
| $757K | ﹤0.01% |
21,245
-11,983
| -36% | -$379K |
|
3027
Assembly Biosciences
ASMB
$516M
| $753K | ﹤0.01% |
16,171
-2,389
| -13% | -$118K |
|
3028
First Bancorp
FNLC
$394M
| $749K | ﹤0.01% |
25,424
+13
| +0.1% | +$388 |
|
3029
Home Bancorp
HBCP
$558M
| $749K | ﹤0.01% |
19,647
| – | – |
|
|
STXB
3030
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $749K | ﹤0.01% |
32,787
-182
| -0.6% | -$4.21K |
|
|
INDT
3031
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $747K | ﹤0.01% |
11,365
+1,977
| +21% | +$127K |
|
3032
Blue Ridge Bankshares
BRBS
$314M
| $745K | ﹤0.01% |
+42,473
| New | +$697K |
|
|
EBTC
3033
DELISTED
Enterprise Bancorp
EBTC
| $744K | ﹤0.01% |
22,688
+867
| +4% | +$29.6K |
|
3034
Genie Energy
GNE
$373M
| $741K | ﹤0.01% |
117,185
+10,174
| +10% | +$62.3K |
|
|
OSG
3035
DELISTED
Overseas Shipholding Group Inc.
OSG
| $738K | ﹤0.01% |
352,642
-159,311
| -31% | -$359K |
|
3036
Spyre Therapeutics
SYRE
$8.81B
| $737K | ﹤0.01% |
4,231
-200
| -5% | -$36.3K |
|
3037
Cadiz
CDZI
$264M
| $733K | ﹤0.01% |
53,895
-2,523
| -4% | -$30.2K |
|
3038
Dianthus Therapeutics
DNTH
$6.16B
| $732K | ﹤0.01% |
4,674
+1,258
| +37% | +$231K |
|
3039
DarioHealth
DRIO
$70.2M
| $732K | ﹤0.01% |
+1,712
| New | +$652K |
|
|
ZYXI
3040
DELISTED
Zynex
ZYXI
| $732K | ﹤0.01% |
51,818
+1
| +0% | +$14 |
|
|
ELOX
3041
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $731K | ﹤0.01% |
9,177
+5,107
| +125% | +$426K |
|
|
QTNT
3042
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $729K | ﹤0.01% |
5,005
+264
| +6% | +$42.2K |
|
|
NGMS
3043
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $728K | ﹤0.01% |
11,830
-59
| -0.5% | -$3.08K |
|
|
NBEV
3044
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $728K | ﹤0.01% |
326,300
+82,128
| +34% | +$191K |
|
|
PROS
3045
DELISTED
ProSight Global, Inc.
PROS
| $725K | ﹤0.01% |
56,756
+1,056
| +2% | +$13.5K |
|
3046
Electromed
ELMD
$333M
| $722K | ﹤0.01% |
63,922
-28,769
| -31% | -$294K |
|
3047
First Internet Bancorp
INBK
$229M
| $718K | ﹤0.01% |
23,162
-375
| -2% | -$12.7K |
|
3048
NWPX Infrastructure Inc
NWPX
$1.22B
| $714K | ﹤0.01% |
25,240
+915
| +4% | +$29.1K |
|
3049
Distribution Solutions Group
DSGR
$1.6B
| $712K | ﹤0.01% |
26,582
+1,144
| +4% | +$31.6K |
|
3050
Aterian
ATER
$4.23M
| $711K | ﹤0.01% |
+4,049
| New | +$947K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.